English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Stenotrophomonas has emerged throughout the last years as an important agent of nosocomial infection. The treatment of S. maltophilia is difficult due to the intrinsic and/or acquired resistance to many classes of antibiotics, such as beta-lactams, aminoglycosides and carbapenems. Currently, there still are doubts concerning the accuracy and inter-relation among the several methods of evaluation of the in vitro susceptibility and which antimicrobial agents are more adequate for the treatment.

Susceptibility in vitro of isolates of Stenotrophomonas maltophilia: comparison of three methodologies (disc diffusion, e-test and agar-dilution)